The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Thalassemia intermedia: Revisited
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iron-Chelating Therapy and the Treatment of Thalassemia
Olivieri, N. F., & Brittenham, G. M. (1997) · Blood · doi:10.1182/blood.v89.3.739 · Cited by 1,089
Brittenham, G. M., Griffith, P. M., Nienhuis, A. W., McLaren, C. E., Young, N. S., Tucker, E. E., Allen, C. J., Farrell, D. E., & Harris, J. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409013310902 · Cited by 829
Olivieri, N. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907083410207 · Cited by 728
Cappellini, M. D. (2006) · Blood · doi:10.1182/blood-2005-08-3430 · Cited by 717
Self-citationPhenotype-genotype relationships in monogenic disease: lessons from the thalassaemias
Weatherall, D. J. (2001) · Nature Reviews Genetics · doi:10.1038/35066048 · Cited by 692 · cited 1×
“However, predicting phenotype from genotype in thalassemia intermedia is still difficult due to genetic and environmental modifying factors [10].”
The hypercoagulable state in thalassemia
Eldor, A., & Rachmilewitz, E. A. (2002) · Blood · doi:10.1182/blood.v99.1.36 · Cited by 503
Pennell, D. J. (2006) · Blood · doi:10.1182/blood-2005-07-2948 · Cited by 495
A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders
Perrine, S. P., Ginder, G. D., Faller, D. V., Dover, G. H., Ikuta, T., Witkowska, H. E., Cai, S.-P., Vichinsky, E. P., & Olivieri, N. F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280202 · Cited by 437
IRON ABSORPTION AND LOADING IN β-THALASSÆMIA INTERMEDIA
Pippard, M. J., Warner, G. T., Callender, S. T., & Weatherall, D. J. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92175-5 · Cited by 419
Borgna-Pignatti, C. (2006) · Blood · doi:10.1182/blood-2005-07-2933 · Cited by 376
Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone
Cohen, A. R., Galanello, R., Piga, A., De Sanctis, V., & Tricta, F. (2003) · Blood · doi:10.1182/blood-2002-10-3280 · Cited by 323
Cardiac involvement in thalassemia intermedia: a multicenter study
Aessopos, A., Farmakis, D., Karagiorga, M., Voskaridou, E., Loutradi, A., Hatziliami, A., Joussef, J., Rombos, J., & Loukopoulos, D. (2001) · Blood · doi:10.1182/blood.v97.11.3411 · Cited by 298
Cappellini, M. D., Robbiolo, L., Bottasso, B. M., Coppola, R., Fiorelli, G., & Mannucci, A. P. M. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02376.x · Cited by 297
Self-citationOral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial
Collins, A., Pearson, H., Giardina, P., McDonagh, K., Brusilow, S., & Dover, G. (1995) · Blood · doi:10.1182/blood.v85.1.43.bloodjournal85143 · Cited by 261
Kushner, J. P., Porter, J. P., & Olivieri, N. F. (2001) · Hematology · doi:10.1182/asheducation-2001.1.47 · Cited by 245
The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients
Ceci, A., Baiardi, P., Felisi, M., Cappellini, M. D., Carnelli, V., De Sanctis, V., Galanello, R., Maggio, A., Masera, G., Piga, A., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03554.x · Cited by 215
Self-citationAessopos, A., Farmakis, D., Deftereos, S., Tsironi, M., Tassiopoulos, S., Moyssakis, I., & Karagiorga, M. (2005) · Chest · doi:10.1378/chest.127.5.1523 · Cited by 215
Extended Therapy with Intravenous Arginine Butyrate in Patients with β-Hemoglobinopathies
Sher, G. D., Ginder, G. D., Little, J., Yang, S., Dover, G. J., & Olivieri, N. F. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322404 · Cited by 168
Beta‐thalassaemia intermedia: is it possible consistently to predict phenotype from genotype?
Ho, Hall, ., Luo, Weatherall, & Thein (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00519.x · Cited by 142
Mourad, F. H., Hoffbrand, A. V., Sheikh‐Taha, M., Koussa, S., Khoriaty, A. I., & Taher, A. T. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04240.x · Cited by 140
Self-citationGenetic insights into the clinical diversity of β thalassaemia
Thein, S. L. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04769.x · Cited by 138
Jensen, P. D. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04838.x · Cited by 137
Cividalli, G., Kerem, H., Ezeckiel, E., & Rachmilewitz, E. A. (1978) · Blood · doi:10.1182/blood.v52.2.345.345 · Cited by 136
Olivieri, N. F., Koren, G., Matsui, D. M., Liu, P., Blendis, L. M., Cameron, R., McClelland, R., & Templeton, D. M. (1992) · Blood · doi:10.1182/blood.v79.10.2741.bloodjournal79102741 · Cited by 128
Derchi, G., Forni, G. L., Formisano, F., Cappellini, Galanello, R., D'Ascola, G., Bina, P., Magnano, C., & Lamagna, M. (2005) · PubMed · Cited by 125
Atichartakarn, V., Angchaisuksiri, P., Aryurachai, K., Onpun, S., Chuncharunee, S., Thakkinstian, A., & Atamasirikul, K. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03711.x · Cited by 122
Pulmonary Arterial Hypertension in Previously Splenectomized Patients with β-Thalassemic Disorders
Atichartakarn, V., Likittanasombat, K., Chuncharunee, S., Chandanamattha, P., Worapongpaiboon, S., Angchaisuksiri, P., & Aryurachai, K. (2003) · International Journal of Hematology · doi:10.1007/bf02983382 · Cited by 121
Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia
Bradai, M., Abad, M. T., Pissard, S., Lamraoui, F., Skopinski, L., & de Montalembert, M. (2003) · Blood · doi:10.1182/blood-2003-01-0117 · Cited by 116
Link, G., Konijn, A. M., Breuer, W. V., Cabantchik, Z. I., & Hershko, C. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.116487 · Cited by 110
Hydroxyurea in thalassemia intermedia—a promising therapy
Dixit, A., Chatterjee, T., Mishra, P. P., Choudhry, D. R., Mahapatra, M., Tyagi, S., Kabra, M., Saxena, R., & Choudhry, V. P. (2005) · Annals of Hematology · doi:10.1007/s00277-005-1026-4 · Cited by 107
Eldor, A., Lellouche, F., Goldfarb, A. W., Rachmilewitz, E. A., & Maclouf, J. (1991) · Blood · doi:10.1182/blood.v77.8.1749.1749 · Cited by 103
Life-threatening neurological complications after bone marrow transplantation in children
Uçkan, D., Cetin, M., Yiğitkanli, I., et al. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704749 · Cited by 98
Karimi, M., Darzi, H., & Yavarian, M. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000174386.13109.28 · Cited by 87
Camaschella, C., & Cappellini, M. D. (1995) · PubMed · Cited by 85
Self-citationCamaschella, C., Mazza, U., Roetto, A., Gottardl, E., Parzlale, A., Travl, M., Fattore, S., Bacchlega, D., Fiorelli, G., & Cappellinl, M. D. (1995) · American Journal of Hematology · doi:10.1002/ajh.2830480203 · Cited by 84
Saxon, B. R., Rees, D. C., & Olivieri, N. F. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00719.x · Cited by 78
Genetic determinants of jaundice and gallstones in haemoglobin E β thalassaemia
Premawardhena, A., Fisher, C., Fathiu, F., de Silva, S., Perera, W., Peto, T., Olivieri, N. F., & Weatherall, D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05082-0 · Cited by 75
Treatment of thalassaemia major with phenylbutyrate and hydroxyurea
Olivieri, N. F., Rees, D. C., Ginder, G. D., Thein, S. L., Brittenham, G. M., Waye, J. S., & Weatherall, D. J. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63080-2 · Cited by 67
Rund, D. G., Oron‐Karni, V., Filon, D., Goldfarb, A. W., Rachmilewitz, E. A., & Oppenheim, A. (1997) · American Journal of Hematology · Cited by 65
Wu, K., Chang, J., Tsai, C., & Peng, C. T. (2004) · Annals of Hematology · doi:10.1007/s00277-003-0820-0 · Cited by 64
Pregnancy in patients with β-thalassemia intermedia: Outcome of mothers and newborns
Nassar, A. H., Usta, I. M., Rechdan, J. B., Koussa, S., Inati, A. C., & Taher, A. T. (2006) · American Journal of Hematology · doi:10.1002/ajh.20654 · Cited by 61
Self-citationIron overload and desferrioxamine chelation therapy in β-thalassemia intermedia
Cossu, P., Toccafondi, C., Vardeu, F., Sanna, G., Frau, F., Lobrano, R., Cornacchia, G., Nucaro, A. L., Bertolino, F., Loi, A., et al. (1981) · European Journal of Pediatrics · doi:10.1007/bf00443255 · Cited by 54
Sampietro, M., Cazzola, M., Cappellini, M. D., & Fiorelli, G. (1983) · British Journal of Haematology · doi:10.1111/j.1365-2141.1983.tb02854.x · Cited by 51
Self-citationIron metabolism in thalassemia intermedia.
Fiorelli, G., Fargion, S. R., Piperno, A., Battafarano, N., & Cappellini, M. D. (1990) · PubMed · Cited by 48
Self-citationOvercoming the challenge of patient compliance with iron chelation therapy
Cappellini, M. D. (2005) · Seminars in Hematology · doi:10.1053/j.seminhematol.2005.01.001 · Cited by 45
Self-citationJuvenile Leg Ulceration in β-Thalassemia Major and Intermedia
Gimmon, Z., Wexler, M. R., & Rachmilewitz, E. A. (1982) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-198202000-00023 · Cited by 44
Gharzuddine, W. (2002) · European Journal of Echocardiography · doi:10.1053/euje.2001.0114 · Cited by 40
Improving adherence with deferoxamine regimens for patients receiving chronic transfusion therapy
Treadwell, M. J., & Weissman, L. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90064-2 · Cited by 37
Intrathoracic Masses Due to Extramedullary Hematopoiesis
Castelli, R., Graziadei, G., Karimi, M., et al. (2004) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200411000-00012 · Cited by 36
The molecular basis for phenotypic variability of the common thalassaemias
Weatherall, D. J. (1995) · Molecular Medicine Today · doi:10.1016/1357-4310(95)80014-x · Cited by 33
PULMONARY THROMBOEMBOLISM IN β-THALASSEMIA INTERMEDIA: ARE WE AWARE OF THIS COMPLICATION?
Taher, A. T., Abou-Mourad, Y., Abchee, A., Zalloua, P., & Shamseddine, A. I. (2002) · Hemoglobin · doi:10.1081/hem-120005447 · Cited by 32
Self-citationWainscoat, J. S., Thein, S. L., & Weatherall, D. J. (1987) · Blood Reviews · doi:10.1016/0268-960x(87)90029-4 · Cited by 28
Advances in the pathophysiology and treatment of thalassemia
Rund, D. G., & Rachmilewitz, E. A. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(95)00162-z · Cited by 21
Irreversibly sickled cell β-actin: Defective filament formation
Shartava, A., Korn, W. M., Shah, A. K., & Goodman, S. R. (1997) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199706)55:2<83::aid-ajh6>3.0.co;2-z · Cited by 20
11 Bone marrow transplant for the haemoglobinopathies: past, present and future
Apperley, J. F. (1993) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80074-5 · Cited by 17
Cited by
Taher, A. T., Weatherall, D. J., & Cappellini, M. D. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31822-6 · Cited by 807
Self-citationOriga, R. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.173 · Cited by 509
Pulmonary Complications of Sickle Cell Disease
Gladwin, M. T., & Vichinsky, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0804411 · Cited by 470
Taher, A. T., Musallam, K. M., Karimi, M., El-Beshlawy, A., Belhoul, K., Daar, S., Saned, M.-S., El-Chafic, A.-H., Fasulo, M. R., & Cappellini, M. D. (2010) · Blood · doi:10.1182/blood-2009-09-243154 · Cited by 392
Self-citationHemoglobin research and the origins of molecular medicine
Schechter, A. N. (2008) · Blood · doi:10.1182/blood-2008-04-078188 · Cited by 381
Metadata
- Authors
- Taher, A., Isma'eel, H., & Cappellini, M. D.
- Venue
- Blood Cells, Molecules, and Diseases
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 37
- Issue
- 1
- Pages
- 12-20
- ISSN
- 1079-9796 (ISSN-L)
- OpenAlex
- W2109769448
- Cited by
- 319
- References
- 55
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.